OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
August 07, 2008
Bristol-Myers Squibb is seeking to acquire the biopharmaceutical company ImClone Systems (New York) for $4.5 billion or $60 per share. BMS currently holds a 17% stake in ImClone.
August 06, 2008
The pharmaceutical industry?s outsourcing practices receive increased attention as Congress evaluates the role of outsourcing in drug-safety issues.
Strong profitability and good growth prospects bode well for the global market for contract research organizations.
August 02, 2008
CMOs expand capacity and capabilities in high-potency manufacturing to meet strong demand for cytotoxic and other potent drugs.
This year's meeting of the Controlled Release Society unveiled a plethora of research insights.
August 01, 2008
J. Scott Tarrant, executive vice-president of Xceleron, explains the role of microdosing in drug development. He describes how microdose data can be used to predict pharmacological dose absorption, distribution, metabolism, and excretion/pharmacokinetic outcomes using accelerator mass spectrometry.